Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox
The company is raising USD$25 million from investors in Australia, Asia and USA. Topelia Australia, a biotech company established to commercialise a novel ATT treatment for Australians in quarantine, has…